Salicylic Augmentation in Depression
Phase 2
Terminated
- Conditions
- DepressionTreatment Resistant DepressionDepressive DisorderMajor Depressive Disorder
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Jessica Harder
- Target Recruit Count
- 32
- Registration Number
- NCT03152409
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath